Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells. [electronic resource]
Producer: 20160812Description: 30072-87 p. digitalISSN:- 1949-2553
- Animals
- Antineoplastic Agents -- pharmacology
- Blotting, Western
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cation Transport Proteins -- genetics
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cisplatin -- pharmacology
- Copper Transporter 1
- DNA Repair
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm -- genetics
- Humans
- Lung Neoplasms -- drug therapy
- Mice
- Mice, Nude
- Microscopy, Fluorescence
- Mutation
- NIH 3T3 Cells
- Proto-Oncogene Proteins p21(ras) -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.